URO-1, Inc. is a life sciences company dedicated to advancing the tools and workflows used in soft tissue biopsy diagnostics.

The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, cross-disciplinary research teams ...

Dr. Ekta Khurana, an associate professor of systems and computational biomedicine at Weill Cornell Medicine, has received a two-year, $1 million Challenge Award from the Prostate Cancer Foundation to ...

In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit its desired safety ... Read More The post Health Check: Telix jumps first hurdle with its ...

AFL MEDIA personality and former player Sam Newman faces a nervous wait for pathology test results after surgery for prostate ...

Adding hormone therapy to postoperative radiotherapy did not improve OS for most patients ...

Investigators sought to determine the effect of “Smart PSA” guidelines on screening behavior and biopsy outcomes among Black men.

An evaluation of 10 men with prostate cancer found 90% had microplastics in their tumors, with concentrations more than double that found in surrounding benign prostate tissue.The data, which will be ...

Blood tests are the most common way for health professionals to detect and diagnose a range of medical conditions. But can it ...

Results from the phase 2 Daro-PET study (NCT05900973) showed that prostate-specific membrane antigen (PSMA) expression was boosted with short-course darolutamide (Nubeqa) in patients with high-risk ...

Doctors may begin asking if you want prostate cancer screenings when you reach age 50. Whether you have these screenings is your choice – they have benefits and some potential risks. Modern screening ...